Physician

Raji Jacob, MD

According to 2025 Medicare claims, Raji Jacob, MD (NPI: 1538325477) practices nephrology in the Peoria, IL market, with the plurality of this provider's patient population coming from Peoria, IL. This provider's primary affiliated billing organization is RENALCARE ASSOCIATES, S.C. (NPI: 1649300377; TIN: 370995483) and primary practice location at 61615-1152. Jacob is affiliated with the IRCCO (ACO ID: A2619) and OSF Healthcare System (ACO ID: A3289), participating under the MSSP model.

Jacob's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 673 traditional Medicare patients, billed 2,645 HCPCS/CPT codes, and received $222,504 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,502 prescription claims across 513 beneficiaries totaling $321,832 in drug costs, led by Jardiance (Empagliflozin). DME data shows 131 claims. Open Payments data shows 1 records totaling $28. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $232,225 and ending at $321,832. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $0 to $0.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	948	8,506	$278,887
2016	1,007	10,624	$283,638
2017	901	2,872	$260,242
2018	838	3,347	$240,017
2019	948	4,244	$292,974
2020	823	2,651	$250,328
2021	871	2,771	$312,209
2022	767	2,179	$240,446
2023	709	1,916	$201,976
2024	673	2,645	$222,504

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	315	2,869	$232,225
2016	367	4,048	$278,881
2017	400	3,706	$214,035
2018	377	2,930	$221,253
2019	402	2,881	$177,270
2020	382	2,823	$242,229
2021	417	2,868	$181,357
2022	405	2,692	$166,935
2023	466	3,109	$301,440
2024	513	3,502	$321,832

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	44	287	$25,793
2016	43	390	$30,538
2017	25	295	$19,946
2018	N/R	243	$13,260
2019	N/R	264	$20,190
2020	N/R	216	$10,493
2021	N/R	119	$2,828
2022	N/R	111	$2,557
2023	N/R	181	$3,314
2024	N/R	131	$1,731

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	97	100	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	110	294	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	370	655	$61
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	113	295	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	368	643	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	105	5,640	$107,684
Eliquis	Apixaban	14	1,140	$20,686
Ozempic	Semaglutide	20	612	$18,868
Farxiga	Dapagliflozin Propanediol	13	810	$15,399
Januvia	Sitagliptin Phosphate	12	600	$11,172

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	31	$508
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	14	$356
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	34	$342
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	27	$311
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	12	$204

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$28	Boehringer Ingelheim Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Raji Jacob, MD?

Tedicare shows public-source Medicare data for Raji Jacob, MD (NPI 1538325477), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Raji Jacob, MD have ACO affiliation data?

Raji Jacob, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and OSF Healthcare System (MSSP, ACO ID A3289).

What billing organization is linked to Raji Jacob, MD?

Raji Jacob, MD is linked to RENALCARE ASSOCIATES, S.C. (billing NPI 1649300377) in the available physician profile data.

Does Raji Jacob, MD have Open Payments data?

Raji Jacob, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.